发明名称 USE OF PROCALCITONIN (PCT) IN RISK STRATIFICATION AND PROGNOSIS DIAGNOSIS OF PATIENTS WITH PRIMARY, NON-INFECTIOUS DISEASE
摘要 <P>PROBLEM TO BE SOLVED: To provide an in vitro prognosis diagnosis method for a patient having a primary, non-infectious disease. <P>SOLUTION: The in vitro prognosis diagnosis method comprises: determining the level of procalcitonin or fragments thereof of at least 12 amino acids in length, effectively more than 50 amino acids in length, more effectively more than 110 amino acids in length, in a sample obtained from a patient; and correlating the level of procalcitonin or fragments to a risk of the patient to contract a further disease or a medical condition which has not yet been manifested and/or is not yet symptomatic. <P>COPYRIGHT: (C)2013,JPO&INPIT
申请公布号 JP2012237760(A) 申请公布日期 2012.12.06
申请号 JP20120171897 申请日期 2012.08.02
申请人 BRAHMS GMBH 发明人 JOACHIM STRUCK;BERGMANN ANDREAS
分类号 G01N33/74;C12Q1/02;C12Q1/28;G01N33/53 主分类号 G01N33/74
代理机构 代理人
主权项
地址